Cargando…

Porphyria and kidney diseases

The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallet, Nicolas, Karras, Alexandre, Thervet, Eric, Gouya, Laurent, Karim, Zoubida, Puy, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888040/
https://www.ncbi.nlm.nih.gov/pubmed/29644058
http://dx.doi.org/10.1093/ckj/sfx146
_version_ 1783312442436091904
author Pallet, Nicolas
Karras, Alexandre
Thervet, Eric
Gouya, Laurent
Karim, Zoubida
Puy, Hervé
author_facet Pallet, Nicolas
Karras, Alexandre
Thervet, Eric
Gouya, Laurent
Karim, Zoubida
Puy, Hervé
author_sort Pallet, Nicolas
collection PubMed
description The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney diseases. Acute intermittent porphyria causes kidney injury, whereas medical situations associated with end-stage renal disease, such as porphyrin accumulation, iron overload and hepatitis C, participate in the inhibition of uroporphyrinogen decarboxylase and predispose the individual to porphyria cutanea tarda. Even if some of these interactions have been known for a long time, the clinical situations associated with these interrelations have strikingly evolved over time with the advent of new therapeutic strategies for dialysis therapy and a better understanding of the pathophysiological mechanisms of porphyria-associated kidney disease. Physicians should be aware of these interactions. The aim of this review is to summarize the complex interactions between kidney physiology and pathology in the settings of porphyria and to emphasize their often-underestimated importance.
format Online
Article
Text
id pubmed-5888040
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58880402018-04-11 Porphyria and kidney diseases Pallet, Nicolas Karras, Alexandre Thervet, Eric Gouya, Laurent Karim, Zoubida Puy, Hervé Clin Kidney J Genetic Diseases The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney diseases. Acute intermittent porphyria causes kidney injury, whereas medical situations associated with end-stage renal disease, such as porphyrin accumulation, iron overload and hepatitis C, participate in the inhibition of uroporphyrinogen decarboxylase and predispose the individual to porphyria cutanea tarda. Even if some of these interactions have been known for a long time, the clinical situations associated with these interrelations have strikingly evolved over time with the advent of new therapeutic strategies for dialysis therapy and a better understanding of the pathophysiological mechanisms of porphyria-associated kidney disease. Physicians should be aware of these interactions. The aim of this review is to summarize the complex interactions between kidney physiology and pathology in the settings of porphyria and to emphasize their often-underestimated importance. Oxford University Press 2018-04 2018-01-10 /pmc/articles/PMC5888040/ /pubmed/29644058 http://dx.doi.org/10.1093/ckj/sfx146 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Genetic Diseases
Pallet, Nicolas
Karras, Alexandre
Thervet, Eric
Gouya, Laurent
Karim, Zoubida
Puy, Hervé
Porphyria and kidney diseases
title Porphyria and kidney diseases
title_full Porphyria and kidney diseases
title_fullStr Porphyria and kidney diseases
title_full_unstemmed Porphyria and kidney diseases
title_short Porphyria and kidney diseases
title_sort porphyria and kidney diseases
topic Genetic Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888040/
https://www.ncbi.nlm.nih.gov/pubmed/29644058
http://dx.doi.org/10.1093/ckj/sfx146
work_keys_str_mv AT palletnicolas porphyriaandkidneydiseases
AT karrasalexandre porphyriaandkidneydiseases
AT therveteric porphyriaandkidneydiseases
AT gouyalaurent porphyriaandkidneydiseases
AT karimzoubida porphyriaandkidneydiseases
AT puyherve porphyriaandkidneydiseases